Pfizer IncChange company Symbol lookupSelect an option...PFE Pfizer IncNHF NexPoint Strategic Opportunities FundFUAPF Global Cannabis Applications CorpGXG Global X MSCI Colombia ETFATMR Altimar Acquisition Corp IIAMD Advanced Micro Devices IncBC-A BRUNSWICK 6 500 SENIOR NTSWST West Pharmaceutical Services IncITT ITT IncPLBY Plby Group IncGo
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
NHF NexPoint Strategic Opportunities Fund
FUAPF Global Cannabis Applications Corp
GXG Global X MSCI Colombia ETF
ATMR Altimar Acquisition Corp II
AMD Advanced Micro Devices Inc
BC-A BRUNSWICK 6 500 SENIOR NTS
WST West Pharmaceutical Services Inc
ITT ITT Inc
PLBY Plby Group Inc
Health Care : Pharmaceuticals | Large Cap Value
Company profilePfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.
|
|
|
|
| |
Latest Earnings (Q2 ending 06/2021)
- Q2 Non-GAAP earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- $1.07
- Q2 Consensus estimate
- $0.97
Latest Earnings Estimate Range
- Highest
estimate - $1.12
- Mean
estimate - $0.97
- Lowest
estimate - $0.78
Quarterly Consensus Estimates and Ranges
PFE's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.